EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Fibroblast Activation Protein

Sophie C Siegmund, Rudolf A Werner, Frederik L Giesel

PET Clinics · 2026-07 · 21 (3) · 415-422

DOI: 10.1016/j.cpet.2026.02.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PET Clinics, 2026-07. Verfasst von Sophie C Siegmund und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, LMU University Hospital Munich, Marchioninistr. 15, 81377 Munich, Bavaria, Germany. Hauptthemen laut MEDLINE: Fibroblast Activation Protein Alpha, Gelatinases, Membrane Proteins, Molecular Imaging. Die Arbeit nennt 69 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibroblast activation protein (FAP)-targeted PET/CT has been shown to provide high-contrast visualization of stromal activation across numerous desmoplastic tumors, being increasingly used in oncology. As interpretation challenges arise from benign fibroblastic processes, structured reporting is becoming indispensable. Although early explorations of FAP-targeted radionuclide therapy demonstrate feasibility, therapeutic translation remains constrained by rapid tracer washout and a lack of robust clinical trials. This review summarizes current FAP imaging applications along with theranostic approaches. Moreover, we will also shed light on the concept of image-guided strategies, where FAP PET can potentially determine the retention capacities in-vivo before on-set of novel nonradiolabeled, FAP-targeted drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Activation Protein AlphaGelatinasesMembrane ProteinsMolecular ImagingNeoplasmsPositron Emission Tomography Computed TomographySerine EndopeptidasesHumansRadiopharmaceuticals

Stichwörter der Autor:innen

FAP ligandsFAP-RADSPET/CTStandardized reportingTheranostics

Substanzen

Fibroblast Activation Protein AlphaGelatinasesMembrane ProteinsRadiopharmaceuticalsSerine Endopeptidases

Autor:innen und Institutionen

  • Department of Nuclear Medicine, LMU University Hospital Munich, Marchioninistr. 15, 81377 Munich, Bavaria, Germany.
  • Department of Nuclear Medicine, LMU University Hospital Munich, Marchioninistr. 15, 81377 Munich, Bavaria, Germany; Division of Nuclear Medicine and Molecular Imaging, The Russell H Morgan Department of Radiology and Ra…
  • Department of Nuclear Medicine, University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, North-Rhine/Westphalia, Germany; Institute for Radiation Sciences, The University…

Zitieren

APA

Siegmund, S. C., Werner, R. A., & Giesel, F. L. (2026). Fibroblast Activation Protein. PET Clinics, 21(3), 415-422. https://doi.org/10.1016/j.cpet.2026.02.004

Vancouver

Siegmund SC, Werner RA, Giesel FL. Fibroblast Activation Protein. PET Clinics. 2026;21(3):415-422. doi:10.1016/j.cpet.2026.02.004

BibTeX
@article{Siegmund2026,
  author = {Siegmund, Sophie C and Werner, Rudolf A and Giesel, Frederik L},
  title = {Fibroblast Activation Protein},
  journal = {PET Clinics},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {415--422},
  doi = {10.1016/j.cpet.2026.02.004}
}
Kostenlos starten →